Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P100034/S046

Optune HFE Transducer Arrays

Novocure, GmbH · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONP100034/S046

What did the FDA decide?

The FDA record for P100034/S046 lists decision OK30 dated 2026-09-16 for a 30-day notice submitted by Novocure, GmbH. The stated change is a minor modification to the pallet configuration for the maximum load during gamma sterilization of HFE transducer arrays performed at Steris Schweiz. The supplement reason is given as a process change affecting the manufacturer, sterilizer, packager or supplier.

The S046 suffix ties this action to the original PMA P100034, consistent with a supplement rather than a new approval of the device or its indications. The submission describes the reported purpose of a packaging and sterilization process adjustment; it does not establish independent evidence of safety or clinical effectiveness, and the record supplies no detail on pallet geometry, loading limits, dose parameters or validation results. Those specifics are absent from the supplied fields.

FDA approval order statement

approval to implement a minor change to the pallet configuration for the maximum load during gamma sterilization process for the HFE arrays performed at Steris Schweiz
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Sep 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P100034/S046
Regulatory pathway
PMA supplement
Product code
NZK
Decision code
OK30
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, low electric field, tumor treatment.

Product code
NZK
FDA device class
3

For the original device and its historical approval scope, see PMA P100034. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P100034 · Original PMA

    NOVOCURE LTD'S NOVOTTF-100A TREATMENT KIT

  2. P100034/S041 · Related supplement

    Optune Gio - Maxpoint Version 2.0

  3. P100034/S044 · Related supplement

    Optune HFE Transducer Array Soft Part Components

  4. P100034/S046 received

    Application receipt date recorded by FDA.

  5. P100034/S046 · FDA decision

    30-Day Notice

  6. P100034/S045 · Related supplement

    Novocure GmbHs Optune Gio

Timeline entries are records held by MedtechLedger for P100034. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100034

Product / regulatory recordCompanyPathwayDecision dateSource
Novocure, GmbHPMA approvalApr 8, 2011FDA
Novocure, GmbHPMA supplementOct 23, 2025FDA
Optune GioP100034/S043
Novocure, GmbHPMA supplementFeb 25, 2026FDA
Novocure, GmbHPMA supplementApr 9, 2026FDA
Optune GioP100034/S042
Novocure, GmbHPMA supplementJun 4, 2026FDA
Novocure, GmbHPMA supplementSep 18, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Novocure, GmbH

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Neuhofstrasse 21, Baar, 6340

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records